Infectious Diseases

Antimicrobial Resistance (AMR)

Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges of the 21st century, threatening the effectiveness of antibiotics, antivirals, antifungals, and other essential medicines. Increasing misuse and overuse of antimicrobial agents in humans, animals, and agriculture have accelerated the development of resistant pathogens, making infections harder to treat and increasing morbidity, mortality, and healthcare costs worldwide. This discussion provides a comprehensive overview of the mechanisms driving resistance, the factors contributing to its rapid spread, and the urgent need for coordinated strategies to combat AMR. It highlights advancements in surveillance systems, diagnostic tools, and antimicrobial stewardship programs designed to monitor, prevent, and control resistant infections. Special attention is given to the challenges faced by healthcare systems in low- and middle-income countries, where limited access to effective medications, inadequate laboratory infrastructure, and lack of public awareness exacerbate the problem. The discussion also explores innovative solutions, including the development of novel antimicrobial agents, alternative therapies, vaccines, and rapid point-of-care diagnostics. Case studies illustrate successful interventions and lessons learned from both hospital and community settings. Additionally, the role of global collaboration, policy initiatives, and public health campaigns in addressing AMR at local, national, and international levels is emphasized. This discussion aims to equip participants with practical strategies, policy recommendations, and actionable insights to combat antimicrobial resistance, safeguard effective treatments, and protect global public health for future generations.